This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barranger, E. Articles by Uzan, S. Search for Related Content PubMed PubMed Citation Articles by Barranger, E. Articles by Uzan, S. Related Collections Diagnosis

Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast Cancer

From the Departments of Gynecologic and Breast Cancers (EB, SU), Nuclear Medicine (DG, FM, J-NT), and Pathology (MA), Hôpital Tenon, Paris, France.

Correspondence: Address correspondence and reprint requests to: Emmanuel Barranger, MD, Department of Gynecologic and Breast Cancers, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France; Fax: 011-33-156-016-855; E-mail: emmanuel.barranger{at}tnn.ap-hop-paris.fr

Background: The aim of this study was to assess the capacity of positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine axillary lymph node status in patients with breast cancer undergoing sentinel node (SN) biopsy.

Methods: Thirty-two patients with breast cancer and clinically negative axillary nodes were recruited. All patients underwent FDG-PET before SN biopsy. After SN biopsy, all patients underwent complete axillary lymph node (ALN) dissection.

Results: The SNs were identified in all patients. Fourteen patients (43.8%) had metastatic SNs (macrometastatic in seven, micrometastatic in six, and isolated tumor cells in one). The false-negative rate of SN biopsy was 6.6% (1 in 15). FDG-PET identified lymph node metastases in 3 of the 14 patients with positive SNs. The overall sensitivity, specificity, and positive and negative predictive values of FDG-PET in the diagnosis of axillary metastasis were 20%, 100%, 100%, and 58.6%, respectively. No false-positive findings were obtained with FDG-PET.

Conclusions: This study demonstrates the limitations of FDG-PET in the detection of ALN metastases in patients with early breast cancer. In contrast, FDG-PET seems to be a specific method for staging the axilla in breast cancer. SN biopsy can be avoided in patients with positive FDG-PET, in whom complete ALN dissection should be the primary procedure.

Key Words: Fluorodeoxyglucose • Positron emission tomography • Sentinel lymph node • Breast cancer

This article has been cited by other articles:

				B. J. Chae, J. S. Bae, B. J. Kang, S. H. Kim, S. S. Jung, and B. J. Song Positron Emission Tomography-Computed Tomography in the Detection of Axillary Lymph Node Metastasis in Patients with Early Stage Breast Cancer Jpn. J. Clin. Oncol., May 1, 2009; 39(5): 284 - 289. [Abstract] [Full Text] [PDF]

				F. LUMACHI, S. BORSATO, A. TREGNAGHI, G. FERRETTI, M. POVOLATO, D. CECCHIN, M. C. MARZOLA, P. ZUCCHETTA, F. BUI, and A. FASSINA Usefulness of Combined Sestamibi Scintimammography, Axillary Ultrasonography and FNA Cytology in Reducing the Number of Sentinel Node Procedures in Patients with Early-stage Breast Cancer Anticancer Res, February 1, 2009; 29(2): 491 - 494. [Abstract] [Full Text] [PDF]

				C. H. M. van Deurzen, M. de Boer, E. M. Monninkhof, P. Bult, E. van der Wall, V. C. G. Tjan-Heijnen, and P. J. van Diest Non-Sentinel Lymph Node Metastases Associated With Isolated Breast Cancer Cells in the Sentinel Node J Natl Cancer Inst, November 19, 2008; 100(22): 1574 - 1580. [Abstract] [Full Text] [PDF]

				N. C. Hodgson and K. Y. Gulenchyn Is There a Role for Positron Emission Tomography in Breast Cancer Staging? J. Clin. Oncol., February 10, 2008; 26(5): 712 - 720. [Abstract] [Full Text] [PDF]

				E. L. Rosen, W. B. Eubank, and D. A. Mankoff FDG PET, PET/CT, and Breast Cancer Imaging RadioGraphics, October 1, 2007; 27(suppl_1): S215 - S229. [Abstract] [Full Text] [PDF]

				U Veronesi, C De Cicco, V. Galimberti, J. Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann. Onc., March 1, 2007; 18(3): 473 - 478. [Abstract] [Full Text] [PDF]

				A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer Arch Surg, August 1, 2006; 141(8): 783 - 789. [Abstract] [Full Text] [PDF]

				M. Torabi, S. L. Aquino, and M. G. Harisinghani Current Concepts in Lymph Node Imaging J. Nucl. Med., September 1, 2004; 45(9): 1509 - 1518. [Abstract] [Full Text] [PDF]

				E. R. Port and H. S. Cody III Editorial: Don't Give up your Gamma Probe Ann. Surg. Oncol., September 1, 2004; 11(9): 813 - 814. [Full Text] [PDF]